Scottish-based biotech firm Cytomos has raised a funding round of £4 million which was led by existing investors Archangels and includes participation from Old College Capital, Scottish Enterprise and new investor British Business Bank.

Cytomos has developed an advanced cell analysis solution for the biopharma industry. ‘Through its CDS platform, Cytomos empowers biopharma to bring novel therapies to market faster and radically reduce costs by enabling critical decision-making much earlier’. Funds will further the development of its technology and support the expansion of its team.